Rejuvenate Bio is a biotechnology startup founded in 2017, aiming to combat chronic age-related diseases. The company's focus is on leveraging gene expression and epigenetic reprogramming to reverse pre-existing conditions such as heart disease, metabolic disease, and kidney failure in humans. With its slogan "Targeting the core drivers of chronic age-related diseases to reverse pre-existing conditions in humans," Rejuvenate Bio has garnered attention in the health care industry. In April 27, 2021, the company secured a significant $14.58M in a Venture Round investment. Despite the absence of specific headquarters information, the recent investment highlights investor confidence in the potential of Rejuvenate Bio's innovative approach. This substantial funding could signify a pivotal point for the company's trajectory, as it continues to make strides in transforming the landscape of age-related disease treatment.
Rejuvenate Bio
Targeting the core drivers of chronic age-related diseases to reverse pre-existing conditions in humans
General Information
BounceWatch is an independent company data service, not affiliated with Rejuvenate Bio. To contact Rejuvenate Bio, visit rejuvenatebio.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Rejuvenate Bio compare?
A PDF of Rejuvenate Bio and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Rejuvenate Bio soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
From the desk
Is Rejuvenate Bio on your competitive set?
Our desk can watch it and brief you on every move: hiring, funding, leadership, product and pricing.
Book a 7-day ReadoutDiscover More
About Rejuvenate Bio
Business keywords: age-related diseases, gene expression, epigenetic reprogramming, chronic diseases, reversing pre-existing conditions, heart disease, metabolic disease, kidney failure, gene therapy, medical research, anti-aging, precision medicine
Funding Rounds & Investors (3)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Grant | $4.00M | 1 |
California Institute for Regenerative Medicine
|
01 Jul 2024 |
| Series A | $14.58M | 5 |
|
12 Apr 2021 |
| Seed Round | Undisclosed | 3 |
|
01 Jun 2018 |
Rejuvenate Bio Alternatives & Competitors
View All Alternatives
NewLimit is a biotechnology company working to extend human healthspan by developing epigenetic repr...
Targeting the biology of aging
Scaling new heights in the fight against heart disease
FAQ About Rejuvenate Bio
Source: BounceWatch company record for Rejuvenate Bio, https://bouncewatch.com/company/rejuvenate-bio, updated 24 October 2024. When citing, please name BounceWatch and link this page.
